Development of a non-viral gene delivery vector based on the dynein light chain Rp3 and the TAT peptide

Journal of Biotechnology

Volumn 173, Issue 1, 2014, Pages 10-18

  Favaro, M T P ^a   de Toledo, M A S ^a   Alves, R F ^b   Santos, C A ^a   Beloti, L L ^a   Janissen, R ^a   de la Torre, L G ^a   Souza, A P ^a   Azzoni, A R ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dynein light chain Rp3; Gene delivery; Non viral protein vectors; TAT

Indexed keywords

CONFOCAL LASER SCANNING; GENE DELIVERY; INTRACELLULAR TRAFFICKING; LIGHT CHAIN; MEMBRANE-ACTIVE PEPTIDES; NON-VIRAL GENE DELIVERY; NONVIRAL; TAT;

CHAINS; CYTOTOXICITY; ESCHERICHIA COLI; LIPOSOMES; POLYPEPTIDES; RECOMBINANT PROTEINS; VECTORS; VIRUSES;

GENE TRANSFER;

CYTOTOXIC FACTOR; DYNEIN ADENOSINE TRIPHOSPHATASE; DYNEIN LIGHT CHAIN RP3; HYBRID PROTEIN; LIPOFECTAMINE; NOCODAZOLE; PROTAMINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DIMERIZATION; DNA BINDING; DNA PACKAGING; ENDOCYTOSIS; ENDOSOME; FEMALE; GENE VECTOR; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; INTERNALIZATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SPERMATOGENESIS; STEREOSPECIFICITY; ZETA POTENTIAL;

DYNEIN LIGHT CHAIN RP3; GENE DELIVERY; NON-VIRAL PROTEIN VECTORS; TAT;

CYTOPLASMIC DYNEINS; GENE PRODUCTS, TAT; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HUMANS; LIPIDS; MICROSCOPY, CONFOCAL; MICROTUBULES; MOLECULAR MIMICRY; PEPTIDES; PROTAMINES; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 84893011138     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2014.01.001     Document Type: Article

References (42)

1. Akita H., Ito R., Khalil I.A., Futaki S., Harashima H. Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Mol. Ther. 2004, 9:443-451.
2. Azzoni A.R., Ribeiro S.C., Monteiro G.A., Prazeres D.M.F. The impact of polyadenylation signals on plasmid nuclease-resistance and transgene expression. J. Gene Med. 2007, 9:392-402.
3. Barbar E., Kleinman B., Imhoff D., Li M., Hays T.S., Hare M. Dimerization and folding of LC8, a highly conserved light chain of cytoplasmic dynein. Biochemistry 2001, 40:1596-1605.
4. Brewer L.R. Protamine-induced condensation and decondensation of the same DNA molecule. Science 1999, 286:120-123.
5. Brooks H., Lebleu B., Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Deliv. Rev. 2005, 57:559-577.
6. Dodding M.P., Way M. Coupling viruses to dynein and kinesin-1. EMBO J. 2011, 30:3527-3539.
7. Douglas M.W. Herpes simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transport. J. Biol. Chem. 2004, 279:28522-28530.
8. Döhner K., Nagel C.-H., Sodeik B. Viral stop-and-go along microtubules: taking a ride with dynein and kinesins. Trends Microbiol. 2005, 13:320-327.
9. Edelstein M.L., Abedi M.R., Wixon J. Gene therapy clinical trials worldwide to 2007 - an update. J. Gene Med. 2007, 9:833-842.
10. Erazo-Oliveras A., Muthukrishnan N., Baker R., Wang T.-Y., Pellois J.-P. Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals 2012, 5:1177-1209.
11. Ferrer-Miralles N., Vázquez E., Villaverde A. Membrane-active peptides for non-viral gene therapy: making the safest easier. Trends Biotechnol. 2008, 26:267-275.
12. Freitas S.S., Azzoni A.R., Santos J.A.L., Monteiro G.A., Prazeres D.M.F. On the stability of plasmid DNA vectors during cell culture and purification. Mol. Biotechnol. 2007, 36:151-158.
13. Ganta S., Devalapally H., Shahiwala A., Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control. Release 2008, 126:187-204.
14. Gump J.M., Dowdy S.F. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol. Med. 2007, 13:443-448.
15. Hall J., Karplus P.A., Barbar E. Multivalency in the assembly of intrinsically disordered dynein intermediate chain. J. Biol. Chem. 2009, 284:33115-33121.
16. Holzbaur E.L., Vallee R.B. Dyneins: molecular structure and cellular function. Annu. Rev. Cell Biol. 1994, 10:339-372.
17. Kamiya H., Fujimura Y., Matsuoka I., Harashima H. Visualization of intracellular trafficking of exogenous DNA delivered by cationic liposomes. Biochem. Biophys. Res. Commun. 2002, 298:591-597.
18. Kay M.A. State-of-the-art gene-based therapies: the road ahead. Nat. Rev. Genet. 2011, 12:316-328.
19. King S.M. The dynein microtubule motor. Biochim. Biophys. Acta 2000, 1496:1-16.
20. Lo K.W.H. The 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulation. J. Biol. Chem. 2004, 280:8172-8179.
21. Lukacs G.L., Haggie P., Seksek O., Lechardeur D., Freedman N., Verkman A.S. Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. 2000, 275:1625-1629.
22. Lv H., Zhang S., Wang B., Cui S., Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 2006, 114:100-109.
23. Makokha M., Hare M., Li M., Hays T., Barbar E. Interactions of cytoplasmic dynein light chains Tctex-1 and LC8 with the intermediate chain IC74. Biochemistry 2002, 41:4302-4311.
24. Mastrobattista E., van der Aa M.A.E.M., Hennink W.E., Crommelin D.J.A. Artificial viruses: a nanotechnological approach to gene delivery. Nat. Rev. Drug Discov. 2006, 5:115-121.
25. Medina-Kauwe L.K., Xie J., Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther. 2005, 12:1734-1751.
26. Mesika A., Kiss V., Brumfeld V., Ghosh G., Reich Z. Enhanced intracellular mobility and nuclear accumulation of DNA plasmids associated with a karyophilic protein. Hum. Gene Ther. 2005, 16:200-208.
27. Moschos S.A., Jones S.W., Perry M.M., Williams A.E., Erjefalt J.S., Turner J.J., Barnes P.J., Sproat B.S., Gait M.J., Lindsay M.A. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug. Chem. 2007, 18:1450-1459.
28. Moseley G.W., Leyton D.L., Glover D.J., Filmer R.P., Jans D.A. Enhancement of protein transduction-mediated nuclear delivery by interaction with dynein/microtubules. J. Biotechnol. 2010, 145:222-225.
29. Nitin N., LaConte L., Rhee W.J., Bao G. Tat peptide is capable of importing large nanoparticles across nuclear membrane in digitonin permeabilized cells. Ann. Biomed. Eng. 2009, 37:2018-2027.
30. Ruponen M., Arkko S., Urtti A., Reinisalo M., Ranta V.-P. Intracellular DNA release and elimination correlate poorly with transgene expression after non-viral transfection. J. Control. Release 2009, 1-6.
31. Said Hassane F., Saleh A.F., Abes R., Gait M.J., Lebleu B. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell. Mol. Life Sci. 2009, 67:715-726.
32. Spagnou S., Miller A.D., Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 2004, 43:13348-13356.
33. Sugita T., Yoshikawa T., Mukai Y., Yamanada N., Imai S., Nagano K., Yoshida Y., Shibata H., Yoshioka Y., Nakagawa S., Kamada H., Tsunoda S.-I., Tsutsumi Y. Comparative study on transduction and toxicity of protein transduction domains. Br. J. Pharmacol. 2009, 153:1143-1152.
34. Suh J.J., Wirtz D.D., Hanes J.J. Efficient active transport of gene nanocarriers to the cell nucleus. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3878-3882.
35. Toledo M.A.S., Favaro M.T.P., Alves R.F., Santos C.A., Beloti L.L., Crucello A., Santiago A.S., Mendes J.S., Horta M.A.C., Aparicio R., Souza A.P., Azzoni A.R. Characterization of the human dynein light chain Rp3 and its use as a non-viral gene delivery vector. Appl. Microbiol. Biotechnol. 2013, 10.1007/s00253-013-5239-5.
36. Toledo M.A.S., Janissen R., Favaro M.T.P., Cotta M.A., Monteiro G.A., Prazeres D.M.F., Souza A.P., Azzoni A.R. Development of a recombinant fusion protein based on the dynein light chain LC8 for non-viral gene delivery. J. Control. Release 2012, 159:222-231.
37. Tzfira T. On tracks and locomotives: the long route of DNA to the nucleus. Trends Microbiol. 2006, 14:61-63.
38. Vázquez E., Ferrer-Miralles N., Villaverde A. Peptide-assisted traffic engineering for nonviral gene therapy. Drug Discov. Today 2008, 13:1067-1074.
39. Williams J.C. Crystal structure of dynein light chain TcTex-1. J. Biol. Chem. 2005, 280:21981-21986.
40. Won Y.-W., Lim K.S., Kim Y.-H. Intracellular organelle-targeted non-viral gene delivery systems. J. Control. Release 2011, 1-11.
41. Yamano S., Dai J., Yuvienco C., Khapli S., Moursi A.M., Montclare J.K. Modified Tat peptide with cationic lipids enhances gene transfection efficiency via temperature-dependent and caveolae-mediated endocytosis. J. Control. Release 2011, 152:278-285.
42. Zhang S., Zhao B., Jiang H., Wang B., Ma B. Cationic lipids and polymers mediated vectors for delivery of siRNA. J. Control. Release 2007, 123:1-10.